Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Experimental Physicists Find Clues into How Radiotherapy Kills Cancer Cells

By LabMedica International staff writers
Posted on 29 Oct 2014
A new discovery in experimental physics has implications for a better determination of the process in which radiotherapy destroys cancer cells. More...


Dr. Jason Greenwood from Queen’s University Belfast (Ireland) Center for Plasma Physics collaborated with scientists from Italy and Spain on the work on electrons, and published this groundbreaking finding October 17, 2014, in the international journal Science. By means of some of the shortest laser pulses, the researchers employed strobe lighting to monitor the ultra-fast movement of the electrons within a nanometer-sized molecule of amino acid. The resulting oscillations—lasting for 4,300 attoseconds—amount to the fastest process ever observed in a biologic structure.

Dr. Greenwood said, “Explaining how electrons move on the nanoscale is crucial for the understanding of a range of processes in matter as it is this charge which initiates many biological, chemical, and electrical processes. For instance, the charge produced from the interaction of ionizing radiation with DNA and its subsequent ultra-fast movement can lead to damage of the DNA and cell death which is exploited in radiotherapy to treat cancer. This knowledge is therefore important for understanding the action of radiotherapy beams in cancer treatment. Being able to describe how light interacts with electrons on these timescales could also lead to improvements in how light is converted into electricity in solar cells or faster microprocessors, which use light rather than electrical signals for switching transistors.”

The research was performed by Queen’s School of Mathematics and Physics in collaboration with the Politecnico Milano (Italy), the Universidad Autónoma of Madrid (Spain), University of Trieste (Italy), and Institute of Photonics and Nanotechnologies IFN-CNR (Padua, Italy).

Dr. Greenwood concluded, “This research will hopefully open up the emerging field of attosecond science which seeks to understand how ultrafast electrons play a key role in chemistry, biology and nanotechnology. This is very early research but this new field of ultrafast light-induced electronics is likely to have an impact in biology, chemistry and materials in the next five to 10 years. Practical applications down the line may include improvements in cancer radiotherapy, highly efficient solar cells, and much faster computer processors.”

Related Links:

Queen’s University Belfast
Politecnico Milano 
Universidad Autónoma of Madrid 



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.